Literature DB >> 20188764

Optimization of shRNA inhibitors by variation of the terminal loop sequence.

Nick C T Schopman1, Ying Poi Liu, Pavlina Konstantinova, Olivier ter Brake, Ben Berkhout.   

Abstract

Gene silencing by RNA interference (RNAi) can be achieved by intracellular expression of a short hairpin RNA (shRNA) that is processed into the effective small interfering RNA (siRNA) inhibitor by the RNAi machinery. Previous studies indicate that shRNA molecules do not always reflect the activity of corresponding synthetic siRNAs that attack the same target sequence. One obvious difference between these two effector molecules is the hairpin loop of the shRNA. Most studies use the original shRNA design of the pSuper system, but no extensive study regarding optimization of the shRNA loop sequence has been performed. We tested the impact of different hairpin loop sequences, varying in size and structure, on the activity of a set of shRNAs targeting HIV-1. We were able to transform weak inhibitors into intermediate or even strong shRNA inhibitors by replacing the loop sequence. We demonstrate that the efficacy of these optimized shRNA inhibitors is improved significantly in different cell types due to increased siRNA production. These results indicate that the loop sequence is an essential part of the shRNA design. The optimized shRNA loop sequence is generally applicable for RNAi knockdown studies, and will allow us to develop a more potent gene therapy against HIV-1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188764     DOI: 10.1016/j.antiviral.2010.02.320

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  21 in total

1.  SHAPE-directed discovery of potent shRNA inhibitors of HIV-1.

Authors:  Justin T Low; Stefanie A Knoepfel; Joseph M Watts; Olivier ter Brake; Ben Berkhout; Kevin M Weeks
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

2.  Directed HIV-1 evolution of protease inhibitor resistance by second-generation short hairpin RNAs.

Authors:  Nick C T Schopman; Anja Braun; Ben Berkhout
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

3.  Identification of loop nucleotide polymorphisms affecting microRNA processing and function.

Authors:  Xiaoxing Xiong; Xianhui Kang; Yueying Zheng; Sibiao Yue; Shengmei Zhu
Journal:  Mol Cells       Date:  2013-11-14       Impact factor: 5.034

Review 4.  Selection of RNAi-based inhibitors for anti-HIV gene therapy.

Authors:  Stefanie A Knoepfel; Mireille Centlivre; Ying Poi Liu; Fatima Boutimah; Ben Berkhout
Journal:  World J Virol       Date:  2012-06-12

5.  Toward optimization of AgoshRNA molecules that use a non-canonical RNAi pathway: variations in the top and bottom base pairs.

Authors:  Elena Herrera-Carrillo; Alex Harwig; Ben Berkhout
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 6.  Guidelines for the optimal design of miRNA-based shRNAs.

Authors:  Xavier Bofill-De Ros; Shuo Gu
Journal:  Methods       Date:  2016-04-12       Impact factor: 3.608

7.  IGF-I signaling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells.

Authors:  Ping Zhou; Sarah C Baumgarten; Yanguang Wu; Jill Bennett; Nicola Winston; Jennifer Hirshfeld-Cytron; Carlos Stocco
Journal:  Mol Endocrinol       Date:  2013-01-22

8.  Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  Stefanos Kalomoiris; Andrew C Cicchetto; Kinga Lakatos; Jan A Nolta; Fernando A Fierro
Journal:  J Cell Biochem       Date:  2016-03-08       Impact factor: 4.429

9.  Functional selection of shRNA loops from randomized retroviral libraries.

Authors:  Stig Mølgaard Rask Jensen; Alexander Schmitz; Finn Skou Pedersen; Jørgen Kjems; Jesper Bertram Bramsen
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

10.  Dicer-independent processing of short hairpin RNAs.

Authors:  Ying Poi Liu; Nick C T Schopman; Ben Berkhout
Journal:  Nucleic Acids Res       Date:  2013-02-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.